Apart from breast cancer, it has been reported that a high SLC20A1 expression is associated with poor prognoses in pancreatic cancer using Kaplan-Meier and COX hazards analyses of overall survival [39, 40]. This evidence concerns the gene SLC20A1 and familial pancreatic carcinoma.